CEO Corner articles are written by presidents or CEOs of biopharmaceutical or medical device companies that create a drug or device. These articles discuss global industry trends, experiences, and challenges that biopharma CEOs and presidents can relate to and should be aware of. To submit a CEO Corner article, please follow these guidelines.
From Consumer Products CEO To Biopharma CEO
Walter Klemp, CEO of Moleculin, shares several lessons he learned from his consumer-product background.
My Advice To Aspiring Biopharma Entrepreneurs
When it comes to achieving success, a few commonalities have crystallized for me during my 30+ years in the pharma industry. Here I share five key tenets that I have found critical to success over the arc of my career.
Do You Know The 4 Pillars To Drive Stakeholder Value?
Thirty-year pharma veteran Nancy Lurker shares her four pillars on which to build your business and why they are crucial to driving stakeholder value over the mid- to long-term.
The Forgotten Piece Of The Opioid Epidemic — And How It Can Be Addressed
To address the opioid epidemic we need an all-out national prevention effort akin to the one that finally began to slow the AIDS epidemic in the 1990s. Here are four actions that could help “unlock” the problem.
From Academia To Pharma CEO: Challenges And Lessons Learned
“Looking back on my 25 years in academic medical research, I can’t think of a single learning experience that equipped me for the world of entrepreneurship, running a public company, or interacting with the capital markets.”
Realizing Aspirations Through Entrepreneurship
Being the founder and CEO of SQZ Biotech is actually Armon Sharei’s first full-time job. He warns that although people often applaud entrepreneurship, lionize its leaders, and paint it as a glamorous adventure, that isn’t really what it’s like.
Lessons Learned: The Start Of mRNA Technology Development
Can German, American, Chinese, and other companies worldwide work together to advance the mRNA revolution and possibly launch the new “pharmacy of the world?”
Considerations For Effective International Collaborations
While there are many key aspects of a successful international collaboration across many time zones and great distance, in our experience — a collaboration between organizations based in the U.S. and Japan — there are a few essential elements.
Turning The Ocean Liner: How To Advocate For A Breakthrough Treatment Paradigm
Like an ocean liner changing course, the national discussion around “modern” healthcare has moved slowly away from volume toward health outcomes. As such, we in the industry need to be both innovators and advocates for change.
CEO Corner: On Leadership
“I’m often asked what it takes to be a successful biotech CEO, and as one of the relatively few female CEOs in our industry, what it takes to break the proverbial glass ceiling.”
BEYOND THE PRINTED PAGE
Why Top Researchers And Physicians Enter The World Of Biopharma R&D
David Chang, M.D., Ph.D., founder and CEO of Allogene Therapeutics, along with numerous other physicians have opted to become biopharmaceutical executives, but one doesn’t have to go to medical school to be driven to make a difference for patients.
Genmab’s Commercial Engine Aspirations
Jan G. J. van de Winkel, Ph.D., cofounder and CEO of Genmab, discusses the company’s aspirations to eventually commercialize its own products.
Tariff Wars, Politics, And Other Concerns Of 6 Biopharma CEOs For 2020 And Beyond
Six biopharma CEOs talk tariff wars, politics, and other concerns for 2020 and beyond.
LIFE SCIENCE LEADER BLOGS
Brightspot: How A Biopharma VC Makes A Difference For Orphans
Ed Torres, managing partner at Lilly Ventures, shares how he and his wife got involved in making a difference for U.S. orphans.
The CNS Summit — A Caring Community Of Collaborative Solution Finders
Chief editor Rob Wright explains what differentiates the CNS Summit from other biopharmaceutical industry conferences.